D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 149 Citations 90,059 547 World Ranking 452 National Ranking 277
Best female scientists D-index 149 Citations 93,305 671 World Ranking 101 National Ranking 66

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Internal medicine
  • Surgery

Valerie W. Rusch mainly focuses on Lung cancer, Surgery, Adenocarcinoma, Stage and Cancer. Valerie W. Rusch interconnects Carcinoma and Chemotherapy in the investigation of issues within Lung cancer. Her work carried out in the field of Carcinoma brings together such families of science as Retrospective cohort study, Survival analysis and Oncology.

Her Surgery research is multidisciplinary, incorporating elements of Pneumonectomy and Extrapleural Pneumonectomy. Her Adenocarcinoma study incorporates themes from Esophageal cancer, KRAS, Lung, Gefitinib and Esophagus. Her Stage research integrates issues from Lymph node, Mesothelioma, Radiology and Adjuvant therapy.

Her most cited work include:

  • EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib (3725 citations)
  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (3202 citations)
  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (3074 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of investigation include Surgery, Internal medicine, Lung cancer, Oncology and Cancer. Surgery connects with themes related to Pneumonectomy in her study. Her Lung cancer study combines topics in areas such as Stage, Carcinoma, Radiology and Clinical trial.

Her study in the field of Non small cell, non-small cell lung cancer and Lung cancer staging is also linked to topics like In patient. Her study explores the link between Pathology and topics such as Cancer research that cross with problems in Epidermal growth factor receptor. Valerie W. Rusch combines subjects such as Esophagus and KRAS with her study of Adenocarcinoma.

She most often published in these fields:

  • Surgery (36.44%)
  • Internal medicine (30.17%)
  • Lung cancer (28.43%)

What were the highlights of her more recent work (between 2016-2021)?

  • Internal medicine (30.17%)
  • Oncology (25.07%)
  • Lung cancer (28.43%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Internal medicine, Oncology, Lung cancer, Surgery and Cancer. Her biological study spans a wide range of topics, including Prospective cohort study, Atezolizumab, Targeted therapy and Chemotherapy. Her Lung cancer research incorporates elements of Neoadjuvant therapy, Clinical trial, Carcinoma, Radiology and Nivolumab.

Valerie W. Rusch studied Surgery and Pneumonectomy that intersect with Comorbidity. Her Cancer study also includes

  • Mutation together with Cancer research and Genetic testing,
  • MEDLINE which connect with Esophagectomy. Her research integrates issues of Disease and Adenocarcinoma in her study of Stage.

Between 2016 and 2021, her most popular works were:

  • Neoadjuvant PD-1 Blockade in Resectable Lung Cancer (786 citations)
  • Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies. (269 citations)
  • Integrative Molecular Characterization of Malignant Pleural Mesothelioma (232 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

Her primary areas of investigation include Internal medicine, Oncology, Lung cancer, Cancer and Surgery. Her Oncology study integrates concerns from other disciplines, such as Chemotherapy, Carcinoma, Lung, Stage and Prospective cohort study. Her Lung cancer research includes elements of Neoadjuvant therapy, Nivolumab, Clinical trial and Radiology.

Her Clinical trial research is multidisciplinary, incorporating elements of Adjuvant and Mesothelioma. Her Cancer research is multidisciplinary, incorporating perspectives in Mutation and Cancer research. Her research in Surgery intersects with topics in Metastasectomy, Adverse effect and Primary tumor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

William Pao;Vincent Miller;Maureen Zakowski;Jennifer Doherty.
Proceedings of the National Academy of Sciences of the United States of America (2004)

4838 Citations

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson.
Journal of Thoracic Oncology (2011)

4675 Citations

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3773 Citations

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux.
Journal of Thoracic Oncology (2007)

3358 Citations

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Andy Trotti;A.Dimitrios Colevas;Ann Setser;Valerie Rusch.
Seminars in Radiation Oncology (2003)

2819 Citations

Comprehensive genomic characterization of squamous cell lung cancers

Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet.
Nature (2012)

2278 Citations

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta.
Journal of Thoracic Oncology (2016)

1784 Citations

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

James Bean;Cameron Brennan;Jin-Yuan Shih;Gregory Riely.
Proceedings of the National Academy of Sciences of the United States of America (2007)

1745 Citations

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

Nael Martini;Manjit S. Bains;Michael E. Burt;Maureen F. Zakowski.
The Journal of Thoracic and Cardiovascular Surgery (1995)

1346 Citations

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

Kathy S Albain;R Suzanne Swann;Valerie W Rusch;Andrew T Turrisi.
The Lancet (2009)

1336 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Valerie W. Rusch

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 207

Ignacio I. Wistuba

Ignacio I. Wistuba

The University of Texas MD Anderson Cancer Center

Publications: 206

Ming-Sound Tsao

Ming-Sound Tsao

Princess Margaret Cancer Centre

Publications: 181

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 171

Mark G. Kris

Mark G. Kris

Memorial Sloan Kettering Cancer Center

Publications: 158

William D. Travis

William D. Travis

Memorial Sloan Kettering Cancer Center

Publications: 143

John D. Minna

John D. Minna

The University of Texas Southwestern Medical Center

Publications: 141

Marc Ladanyi

Marc Ladanyi

Memorial Sloan Kettering Cancer Center

Publications: 139

Harvey I. Pass

Harvey I. Pass

New York University

Publications: 136

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 136

Thomas A. D'Amico

Thomas A. D'Amico

Duke University

Publications: 134

William Pao

William Pao

Roche (United States)

Publications: 134

Adi F. Gazdar

Adi F. Gazdar

The University of Texas Southwestern Medical Center

Publications: 126

John V. Heymach

John V. Heymach

The University of Texas MD Anderson Cancer Center

Publications: 121

Frank C. Detterbeck

Frank C. Detterbeck

Yale University

Publications: 121

Rafael Rosell

Rafael Rosell

Autonomous University of Barcelona

Publications: 118

Trending Scientists

Anna Cinzia Squicciarini

Anna Cinzia Squicciarini

Pennsylvania State University

Igor Y. Khandros

Igor Y. Khandros

FormFactor (United States)

Nigam P. Rath

Nigam P. Rath

University of Missouri–St. Louis

J. Troe

J. Troe

Max Planck Society

Qiuming Gao

Qiuming Gao

Beihang University

Carlos T. Moraes

Carlos T. Moraes

University of Miami

Peng Jin

Peng Jin

Emory University

Peter Calow

Peter Calow

University of Minnesota

Boddupalli M. Prasanna

Boddupalli M. Prasanna

International Maize and Wheat Improvement Center

Hume Field

Hume Field

University of Queensland

Karl M. Johnson

Karl M. Johnson

University of New Mexico

Ralph E. Milliken

Ralph E. Milliken

Brown University

Gunnar W. Schade

Gunnar W. Schade

Texas A&M University

Steven A. Safren

Steven A. Safren

University of Miami

Peter P. Zandi

Peter P. Zandi

Johns Hopkins University

Simon Stewart

Simon Stewart

Torrens University Australia

Something went wrong. Please try again later.